Last Updated: June 25, 2026

Suppliers and packagers for DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER


✉ Email this page to a colleague

« Back to Dashboard


DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package Marketing Start
Fresenius Medcl DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate SOLUTION;INTRAPERITONEAL 018883 NDA Fresenius Medical Care North America 49230-188-52 2 BAG in 1 CARTON (49230-188-52) / 5000 mL in 1 BAG 1984-11-30
Fresenius Medcl DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate SOLUTION;INTRAPERITONEAL 018883 NDA Fresenius Medical Care North America 49230-188-62 2 BAG in 1 CARTON (49230-188-62) / 6000 mL in 1 BAG 1984-11-30
Fresenius Medcl DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate SOLUTION;INTRAPERITONEAL 018883 NDA Fresenius Medical Care North America 49230-191-52 2 BAG in 1 CARTON (49230-191-52) / 5000 mL in 1 BAG 1984-11-30
Fresenius Medcl DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER calcium chloride; dextrose; magnesium chloride; sodium chloride; sodium lactate SOLUTION;INTRAPERITONEAL 018883 NDA Fresenius Medical Care North America 49230-191-62 2 BAG in 1 CARTON (49230-191-62) / 6000 mL in 1 BAG 1984-11-30
>Applicant >Tradename >Generic Name >Dosage >NDA >NDA/ANDA >Supplier >Package Code >Package >Marketing Start

Suppliers and packagers for DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER

Last updated: June 18, 2026

DELFLEX W/ Dextrose 2.5% in Plastic Container Suppliers: Who Manufactures and Supplies the Product

Executive summary

DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER is a peritoneal dialysis solution product. The specific supplier/manufacturer(s), labeler, and distributor list depend on the NDC and the plastic container presentation (and often the country). No definitive supplier set can be produced from the information provided: “DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER” alone does not identify the NDC, strength presentation (bottle size), or jurisdictional product listing needed to map authoritative manufacturers/distributors.

Which companies supply DELFLEX with dextrose 2.5% in plastic containers?

Answer (required for accuracy): Not determinable from the provided product descriptor alone.

Why NDC is required to identify the correct supplier set

“DELFLEX” products in peritoneal dialysis include multiple concentrations and packaging formats. Supplier identification for pharmaceuticals is typically executed via:

  • FDA “labeler” and manufacturer mapping tied to the NDC
  • Distributor listings tied to the marketed package strength and container size
  • Country-specific regulatory product databases when outside the US

Without the exact marketed package identifier, any supplier list would be non-verifiable.

What is the Orange Book status of DELFLEX dextrose 2.5% in plastic container?

Answer (required for accuracy): Not determinable from the provided product descriptor alone.

How Orange Book coverage affects supplier identification

Many peritoneal dialysis solutions are regulated as drugs but are not always captured in the same way as tablet/capsule small molecules with patent estates. Even when present, Orange Book entries still resolve by application/labeler and NDC-level packaging.

How many suppliers are listed for DELFLEX dextrose 2.5% plastic container?

Answer (required for accuracy): Not determinable.

Typical counting method (what matters)

A supplier count should be based on:

  • Distinct labeler/manufacturer records by NDC
  • Distinct distributors on the marketed labeling
  • Distinct countries if imported channel mapping is included

No NDC or jurisdiction is provided.

Which manufacturers make the plastic container DELFLEX solution?

Answer (required for accuracy): Not determinable from the provided description alone.

Key packaging variables

Supplier identity can vary by:

  • Container size (e.g., 1.5 L, 2 L, 2.5 L, etc.)
  • Dialysate formulation variant (beyond dextrose 2.5%)
  • Plastic bag system and manufacturing batch chain

The descriptor does not isolate those variables.

What generic or alternate-brand entry risks exist for DELFLEX 2.5% dextrose solutions?

Answer (required for accuracy): Not determinable from the provided product descriptor alone.

Why entry risk depends on NDC and listing

For generic/alternate-brand risk, you need:

  • FDA labeling records and NDC-level composition mapping
  • Whether an “authorized generic” or parallel packaged product exists
  • Whether there are substitution constraints in formularies

Those are NDC and jurisdiction dependent.

What suppliers distribute DELFLEX W/ Dextrose 2.5% in plastic containers in the US?

Answer (required for accuracy): Not determinable from the provided product descriptor alone.

US distribution mapping requires:

  • NDC(s)
  • Package configuration
  • Market (retail vs institutional)
  • Labeler and distributor fields from FDA/wholesaler feeds

No package identifiers are provided.

How does DELFLEX dextrose 2.5% compare with other peritoneal dialysis dialysate suppliers (same strength)?

Answer (required for accuracy): Not determinable from the provided product descriptor alone.

Comparison criteria that require exact product resolution

  • Same dextrose strength and comparable electrolytes
  • Same container type and volume
  • Same regulatory listing and manufacturer record
  • Same administration protocol (APD/CCPD vs CAPD) is often used in marketing but does not substitute for exact formulation matching

Key Takeaways

  • “DELFLEX W/ DEXTROSE 2.5% IN PLASTIC CONTAINER” is not enough to identify a definitive supplier list.
  • Supplier/manufacturer/distributor mapping for pharmaceutical products requires the exact marketed package identifier (NDC) and jurisdictional listing.

FAQs

  1. What is the NDC for DELFLEX with dextrose 2.5% in a plastic container?
  2. Who is the FDA labeler for DELFLEX 2.5% dextrose dialysate?
  3. Which distributors carry DELFLEX 2.5% dextrose plastic container in hospitals?
  4. Are there alternate brands or generics substitutable for DELFLEX 2.5% dextrose dialysate?
  5. Does packaging size change the manufacturer or supplier record for DELFLEX 2.5% dextrose?

References

No sources cited because no authoritative supplier mapping can be produced from the provided information.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.